Publication
Dietary 2-oxoglutarate prevents bone loss caused by neonatal treatment with maximal dexamethasone dose
Dietary 2-oxoglutarate prevents bone loss caused by neonatal treatment with maximal dexamethasone dose
Dietary 2-oxoglutarate prevents bone loss caused by neonatal treatment with maximal dexamethasone dose
Dietary 2-oxoglutarate prevents bone loss caused by neonatal treatment with maximal dexamethasone dose
Dietary 2-oxoglutarate prevents bone loss caused by neonatal treatment with maximal dexamethasone dose
Dietary 2-oxoglutarate prevents bone loss caused by neonatal treatment with maximal dexamethasone dose
Dietary 2-oxoglutarate prevents bone loss caused by neonatal treatment with maximal dexamethasone dose
Dietary 2-oxoglutarate prevents bone loss caused by neonatal treatment with maximal dexamethasone dose

Jacek T, Szkopek D, Wychowański P, Donaldson J, Zaworski K, Strutyński M, Kirko S, Prykhodko O, Fedkiv O, Pierzynowski SG and Pierzynowska K (2026) The domestic pig as a translational model of hyperoxaluria: a pilot study of acute and chronic sodium oxalate infusion. Front. Physiol. 16, 1692403. https://doi.org/10.3389/fphys.2025.1692403

Abstract or full text






Wychowański, P.; Pierzynowski, S.G.; Zaworski, K.; Gallotto, R.; Szkopek, D.; Woliński, J.; Donaldson, J.; Jacek, T.; Pierzynowska, K. Dependency of Glucose Homeostasis on Pancreatic Enzymes with Special Reference to Amylase; Study on Healthy and Exocrine Pancreatic Insufficient Pigs. Biomolecules 2026, 16, 172. https://doi.org/10.3390/biom16010172

Abstract or full text






Pierzynowski S.G., Wychowański P., Szczesny W., Galloto R., Zaworski K., Szkopek D., Woliński J., Donaldson J., Pierzynowska K. Algorithm and ninhydrin method allow for measurement of the postprandial appearance of peptides in blood.Sci Rep15, 19704 (2025). https://doi.org/10.1038/s41598-025-04625-w

Abstract or full text







Pierzynowska K, Pierzynowski S, Zaworski K, Gallotto R, Sathe M, Freedman SD, et al. (2025) Validation of dietary whey protein substrate challenge absorption test as an indicator of proteolysis. PLoS One 20(5): e0323730. https://doi.org/10.1371/journal.pone.0323730

Abstract or full text






Donaldson J, Jacek T, Wychowański P, Zaworski K, Szkopek D, Woliński J, Grujic D, Pierzynowski S, Pierzynowska K. Rat Model of Endogenous and Exogenous Hyperammonaemia Induced by Different Diets.International Journal of Molecular Sciences. 2025; 26(5):1818. https://doi.org/10.3390/ijms26051818

Abstract or full text






Sathe, M., Freedman, S.D., Putman, M.S., Gallotto, R., Clarkin, M., Gallotto, D., Pierzynowska, K.G., & Borowitz, D.S. (2025). Results of a clinical trial of ANG003, a non-porcine pancreatic enzyme replacement therapy, in people with cystic fibrosis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. https://doi.org/10.1016/j.jcf.2025.07.008

Abstract or full text





Zaworski K, Wychowański P, Szkopek D, Woliński J, Donaldson J, Pierzynowski S, Pierzynowska K. The Regulatory Role of Pancreatic Enzymes in the Maintenance of Small Intestinal Structure and Enterocyte Turnover with Special Reference to Alpha Amylase.International Journal of Molecular Sciences. 2025; 26(1):249. https://doi.org/10.3390/ijms26010249

Abstract or full text





Pierzynowska K, Wychowański P, Mosiichuk N, et al. Isolated digesta as an effective and reliableex vivosystem to study the release profile of drug formulations: study onCandida utilisurate oxidase.Journal of Animal and Feed Sciences. 2025;34(1):20–28. https://doi.org/10.22358/jafs/190440/2024

Abstract or full text








Selected publications